Literature DB >> 9721966

Infective endocarditis due to Stenotrophomonas (Xanthomonas) maltophilia.

R G Munter1, A M Yinnon, Y Schlesinger, C Hershko.   

Abstract

Stenotrophomonas maltophilia (formerly Xanthomonas maltophilia) is a gram-negative bacillus increasingly associated with serious nosocomial infections. Here, the case of a 69-year-old female patient who developed prosthetic valve endocarditis associated with this organism is described. A review of the literature revealed only 18 previous reports; eight involved native valves, the remainder prosthetic valves. Most cases were associated with risk factors, including intravenous drug abuse (6 patients), infected intravenous lines (4 patients) or a recent invasive procedure (3 patients). The course of the disease appears to be indolent, but is otherwise similar to infective endocarditis associated with other gram-negative organisms. Antimicrobial therapy is complicated by multiple drug resistance of the organism; cotrimoxazole may be beneficial, if the isolate is susceptible, in combination with another agent. Five of nine (55%) patients who underwent valve replacement survived, as compared to three of seven (43%) who received antibiotic therapy only. Hence, surgery is not essential for survival in every case and depends as much on the individual patient's course as on established criteria for valve replacement in prosthetic valve endocarditis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9721966     DOI: 10.1007/bf01709460

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  31 in total

1.  Nosocomial infections due to Xanthomonas maltophilia (Pseudomonas maltophilia) in patients with cancer.

Authors:  N Khardori; L Elting; E Wong; B Schable; G P Bodey
Journal:  Rev Infect Dis       Date:  1990 Nov-Dec

2.  Septic prepatellar bursitis caused by Stenotrophomonas (Xanthomonas) maltophilia.

Authors:  K A Papadakis; S E Vartivarian; M E Vassilaki; E J Anaissie
Journal:  Clin Infect Dis       Date:  1996-02       Impact factor: 9.079

3.  Prosthetic valve endocarditis. Analysis of 38 cases.

Authors:  W E Dismukes; A W Karchmer; M J Buckley; W G Austen; M N Swartz
Journal:  Circulation       Date:  1973-08       Impact factor: 29.690

4.  Pseudomonas maltophilia infections in man.

Authors:  G L Gilardi
Journal:  Am J Clin Pathol       Date:  1969-01       Impact factor: 2.493

Review 5.  Indications for cardiac surgery in patients with active infective endocarditis.

Authors:  S G Alsip; E H Blackstone; J W Kirklin; C G Cobbs
Journal:  Am J Med       Date:  1985-06-28       Impact factor: 4.965

6.  Susceptibility of Pseudomonas maltophilia to antimicrobial agents, singly and in combination.

Authors:  T P Felegie; V L Yu; L W Rumans; R B Yee
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

7.  Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy.

Authors:  J W Chow; M J Fine; D M Shlaes; J P Quinn; D C Hooper; M P Johnson; R Ramphal; M M Wagener; D K Miyashiro; V L Yu
Journal:  Ann Intern Med       Date:  1991-10-15       Impact factor: 25.391

8.  Associated mortality and clinical characteristics of nosocomial Pseudomonas maltophilia in a university hospital.

Authors:  A J Morrison; K K Hoffmann; R P Wenzel
Journal:  J Clin Microbiol       Date:  1986-07       Impact factor: 5.948

9.  Pseudomonas maltophilia causing heroin-associated infective endocarditis.

Authors:  V L Yu; L W Rumans; E J Wing; R McLeod; F N Sattler; R M Harvey; S C Deresinski
Journal:  Arch Intern Med       Date:  1978-11

Review 10.  Polymicrobial infective endocarditis in the 1980s.

Authors:  L M Baddour; J Meyer; B Henry
Journal:  Rev Infect Dis       Date:  1991 Sep-Oct
View more
  6 in total

1.  In vitro activities of membrane-active peptides alone and in combination with clinically used antimicrobial agents against Stenotrophomonas maltophilia.

Authors:  A Giacometti; O Cirioni; M S Del Prete; F Barchiesi; M Fortuna; D Drenaggi; G Scalise
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

2.  Multiple antibiotic resistance in Stenotrophomonas maltophilia: involvement of a multidrug efflux system.

Authors:  L Zhang; X Z Li; K Poole
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

3.  Cluster of Stenotrophomonas maltophilia endocarditis after prosthetic valve replacement.

Authors:  Manica Müller-Premru; Tone Gabrijelcic; Borut Gersak; Jana Kolman; Natasa Svent-Kucina; Vesna Spik; Tatjana Lejko-Zupanc
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

4.  The antimicrobial susceptibility of Stenotrophomonas maltophilia isolates using three different methods and their genetic relatedness.

Authors:  Müserref Tatman-Otkun; Saban Gürcan; Burçin Ozer; Bayram Aydoslu; Sebnem Bukavaz
Journal:  BMC Microbiol       Date:  2005-05-09       Impact factor: 3.605

5.  Antibiogram of Stenotrophomonas maltophilia Isolated From Nkonkobe Municipality, Eastern Cape Province, South Africa.

Authors:  Anthony Ayodeji Adegoke; Anthony I Okoh
Journal:  Jundishapur J Microbiol       Date:  2014-12-10       Impact factor: 0.747

Review 6.  Infective endocarditis caused by Stenotrophomonas maltophilia: A report of two cases and review of literature.

Authors:  Shaik Subhani; Amar N Patnaik; Ramachandra Barik; Lalita Nemani
Journal:  Indian Heart J       Date:  2016-01-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.